There is no such thing as “the best drug for lung cancer”. Lung cancer is a kind of malignant tumor originated from the epithelium of bronchial mucosa. Clinical drugs for lung cancer treatment include EGFR-tyrosine kinase inhibitors such as erlotinib and gefitinib, anti-tumor angiogenesis targeting drugs such as bevacizumab and amilorotinib, as well as chemotherapeutic drugs such as etoposide, cisplatin, irinotecan, nedaplatin, etc., which to a certain extent can kill the tumor cells, control the proliferation of tumors, and reduce the angiogenesis in the tumor tissues to achieve the purpose of treating lung cancer. and reduce angiogenesis in tumor tissues, so as to achieve the purpose of treating lung cancer. In addition to the above medication, lung cancer patients can also take other treatments such as surgery, radiotherapy, bronchial artery infusion chemotherapy, transbronchoscopic intervention therapy and so on. It is recommended that lung cancer patients should go to regular hospitals in time, follow the advice of specialists for standardized diagnosis and treatment, and follow up regularly.